Correction to "SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial"
Lancet Reg Health Southeast Asia
.
2022 Dec:7:100110.
doi: 10.1016/j.lansea.2022.100110.
Epub 2022 Nov 6.
Authors
Monika Tandon
1
,
Wen Wu
2
,
Keith Moore
3
,
Stephen Winchester
4
,
Yuan-Po Tu
5
,
Christopher Miller
3
,
Rahul Kodgule
1
,
Amol Pendse
1
,
Shabbir Rangwala
1
,
Shashank Joshi
6
Affiliations
1
Glenmark Pharmaceuticals Limited, Mumbai, India.
2
Glenmark Pharmaceuticals Limited, UK.
3
SaNOtize Research & Development Corp., Vancouver, British Columbia, Canada.
4
Frimley Health NHS Foundation Trust, Surrey, England.
5
The Everett Clinic-Part of Optum, Everett, Washington.
6
Lilavati Hospital and Research Centre, Mumbai, India.
PMID:
36373109
PMCID:
PMC9637381
DOI:
10.1016/j.lansea.2022.100110
Abstract
[This corrects the article DOI: 10.1016/j.lansea.2022.100036.].
© 2022 The Author(s).
Publication types
Published Erratum